Inhibition of FGF using the small-molecule multi-FGF receptor blocker SSR128129 radiosensitizes human glioblastoma [20], indicating that targeting of the FGF2–FGFR pathway might be of interest when aiming to radiosensitize human glioblastoma. The gene discussed is FGF2; the disease is glioblastoma.